Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver

作者: Mark J Neveu , James R Hully , Karlee L Babcock , Elliot L Hertzberg , Bruce J Nicholson

DOI: 10.1242/JCS.107.1.83

关键词: Gene expressionTumor promotionBiologyCellular localizationImmunologyMolecular biologyCarcinogenesisNorthern blotDownregulation and upregulationConnexinImmunostaining

摘要: Although several abnormalities in gap junction (GJ) structure and/or function have been described neoplasms, the molecular mechanisms responsible for many of alterations remain unknown. The identification a family GJ proteins, termed connexins, prompted this study connexin32 (Cx32), connexin26 (Cx26) and connexin43 (Cx43) expression during rat hepatocarcinogenesis. Using antibody, cDNA cRNA probes, we investigated connexin mRNA protein preneoplastic neoplastic livers. In normal liver, Cx32 is expressed hepatocytes throughout hepatic acinus, Cx26 restricted to periportal hepatocytes, Cx43 by mesothelial cells forming Glisson9s capsule. Most altered foci generated diethylnitrosamine (DEN) initiation either phenobarbital (PB) or 2,3,7,8-dichlorodibenzo-p-dioxin (TCDD) promotion exhibited decreased increased staining. Foci from protocol failed display immunoreactivity. majority PB-promoted foci, immunoreactivity independently changes abundance. Continuous thymidine labeling, following cessation PB promotion, showed that downregulation staining reversible are promoter-dependent growth, but irreversible lesions promoter-independent growth. Hepatic neoplasms rats initiated with DEN promoted TCDD also displayed modified expression. While all 24 studied were deficient punctate staining, cellular localization these proteins was apparent some tumors. Immunoblotting crude tissue extracts revealed disordered immunoreactive bands electrophoretic mobility. These observations show hepatomas may downregulate through primary post-translational modifications. Northern blotting total tumor mRNAs demonstrate consistent abundance Cx32, transcripts. Some tumors steady-state transcripts without observable immunoreactivity, indicating Increased levels found immunostaining always localized nonparenchymal cells. Areas bile duct proliferation cholangiomas whereas, cholangiocarcinomas findings differential induction, represent common modifications our results imply connexins useful markers boundary between progression, fail use mechanism modify

参考文章(59)
H. C. Pitot, M. J. Neveu, J. H. Hully, L. Sargent, D. Paul, B. Nicholson, Gene Activation and Deactivation during Multistage Hepatocarcinogenesis in the Rat Springer US. pp. 49- 64 ,(1991) , 10.1007/978-1-4615-3694-9_6
Ronald S. Weinstein, Frederick B. Merk, Joseph Alroy, The structure and function of intercellular junctions in cancer. Advances in Cancer Research. ,vol. 23, pp. 23- 89 ,(1976) , 10.1016/S0065-230X(08)60543-6
Richard L. Swarm, Dorothy Feldman, Janet Becker, Ultrastructural Study of Rat Liver and Liver Neoplasms after Long-Term Treatment with Phenobarbital Cancer Research. ,vol. 41, pp. 2151- 2162 ,(1981)
R. A. Faris, H. A. Dunsford, D. C. Hixson, B. A. Monfils, Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system. Cancer Research. ,vol. 51, pp. 1308- 1317 ,(1991)
Eric C. Beyer, David L. Paul, Daniel A. Goodenough, Connexin family of gap junction proteins The Journal of Membrane Biology. ,vol. 116, pp. 187- 194 ,(1990) , 10.1007/BF01868459
L.S. Musil, D.A. Goodenough, Gap junctional intercellular communication and the regulation of connexin expression and function. Current Opinion in Cell Biology. ,vol. 2, pp. 875- 880 ,(1990) , 10.1016/0955-0674(90)90086-T
Michael VL Bennett, LC Barrio, TA Bargiello, DC Spray, EL Hertzberg, JC Saez, Gap junctions: new tools, new answers, new questions. Neuron. ,vol. 6, pp. 305- 320 ,(1991) , 10.1016/0896-6273(91)90241-Q
Masahito Oyamada, Vladimir A. Krutovskikh, Marc Mesnil, Christian Partensky, Françoise Berger, Hiroshi Yamasaki, Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Molecular Carcinogenesis. ,vol. 3, pp. 273- 278 ,(1990) , 10.1002/MC.2940030507